Clinical importance of micrometastasis in sentinel lymph nodes

Breast

Volumn 20, Issue 1, 2011, Pages 31-33

  Ozcinar, Beyza ^a   Muslumanoglu, Mahmut ^a   Igci, Abdullah ^a   Gurdal, Sibel O ^a   Yavuz, Ekrem ^a   Kecer, Mustafa ^a   Dagoglu, Temel ^a   Ozmen, Vahit ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Axillary lymph node dissection; Isolated tumor cells; Local recurrence; Micrometastasis; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

EID: 79451476150     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2010.08.005     Document Type: Article

References (18)

1. Guiliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-401. PMID: 8092905.
2. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998, 339:941-946. PMID: 9753708.
3. Peintinger F., Reitsamer R., Stranzl H., et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003, 89:648-652. PMID: 12915872.
4. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomised controlled trial. J Clin Oncol 2005, 23:4312-4321. PMID: 15994144.
5. Rosen P.P., Saigo P.E., Braun D.W., et al. Prognosis in stage II (T1N1M0) breast cancer. Ann Surg 1981, 194:576-584. PMID: 6271083.
6. Van der Heiden-van der Loo M., Bezemer P.D., Hennipman A., et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 2006, 32:710-714. PMID: 16765560.
7. Abdesselam S.F., Zervos E.E., Prasad M., et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001, 182:316-320. PMID: 11720662.
8. Weiser M.R., Montgomery L.L., Tan L.K., et al. Lymphovascular invasion enhances the prediction of nonsentinel node metastasis in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001, 8:145-149. PMID: 11258779.
9. Wada N., Imoto S., Yamauchi C., et al. Predictors of tumor involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 2006, 32:29-33. PMID: 16269227.
10. Turner R.R., Chu K.U., Qi K., et al. Pathologic features associated with nonsentinel lymph node metastasis in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000, 89:574-581. PMID: 10931456.
11. Viale G., Mairorano E., Pruneri G., et al. Predicting the risk for additional axillary metastasis in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005, 241:319-325. PMID: 15650643.
12. Huvos A.G., Hutter R.V., Berg J.W., et al. Significance of axillary macrometastasis and micrometastasis in mammary cancer. Ann Surg 1971, 173:44-46. PMID: 5543548.
13. De Mascarel I., Bonichon F., Coindre J.M., et al. Prognostic significance of breast cancer axillary lymph node micrometastasis assessed by two special techniques: reevaluation with longer follow up. Br J Cancer 1992, 66:523-527. PMID: 1520589.
14. Grabau D., Jensen M.B., Rank F., et al. Axillary lymph node micrometastasis in invasive breast cancer: national figures on incidence and overall survival. APMIS 2007, 115:828-837. PMID: 17614850.
15. Bulte C.S.E., Heiden-van der Loo M., Hennipman A. Axillary recurrence rate after tumor negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study. EJSO 2009, 35:25-31. PMID: 18640809.
16. Langer I., Marti W.R., Guller U., et al. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastasis. Ann Surg 2005, 241:152-158. PMID: 15622003.
17. Patani N., Mokbel K. The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat 2009, 143:393-402. PMID: 18425678.
18. Yi M., Meric-Bernstam F., Ross M.I., Akins J.S., Hwang R.F., Lucci A., et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?. Cancer 2008, 113:30-37. PMID: 18457326.